Literature DB >> 29669229

Gene Therapy as a Curative Option for β-Thalassemia.

Alessandra Biffi1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29669229     DOI： 10.1056/NEJMe1802169

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Theranostics of Genetic Diseases.

Authors:  Roberto Gambari; Marina Kleanthous
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

2.  A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy.

Authors:  Sherif M Badawy; Usman Beg; Robert I Liem; Sonali Chaudhury; Alexis A Thompson
Journal:  Blood Adv       Date:  2021-01-26

Review 3.  Responsible Translational Pathways for Germline Gene Editing?

Authors:  Bryan Cwik
Journal:  Curr Stem Cell Rep       Date:  2020-08-21

4.  Evaluation of thyroid hormones and ferritin level in patients with β-thalassemia.

Authors:  Sura Zahim Hussein
Journal:  Med Pharm Rep       Date:  2022-04-28

5.  Revising, Correcting, and Transferring Genes.

Authors:  Bryan Cwik
Journal:  Am J Bioeth       Date:  2020-08       Impact factor: 11.229

Review 6.  Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing.

Authors:  Dito Anurogo; Nova Yuli Prasetyo Budi; Mai-Huong Thi Ngo; Yen-Hua Huang; Jeanne Adiwinata Pawitan
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

7.  Body iron status of children and adolescents with transfusion dependent β-thalassaemia: trends of serum ferritin and associations of optimal body iron control.

Authors:  Tharindi Suriapperuma; Ravindu Peiris; Chamila Mettananda; Anuja Premawardhena; Sachith Mettananda
Journal:  BMC Res Notes       Date:  2018-08-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.